Arovella Therapeutics Ltd
ASX:ALA
Arovella Therapeutics Ltd
ASX:ALA
Price:
0.09
AUD
-3.23%
Market Closed
Market Cap:
AU$108.1m
Balance Sheet
Balance Sheet Decomposition
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Balance Sheet Decomposition is not available for
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Balance Sheet
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Currency: AUD
| Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
2
|
0
|
4
|
1
|
7
|
6
|
5
|
13
|
21
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
2
|
0
|
4
|
1
|
7
|
6
|
5
|
13
|
21
|
|
| Short-Term Investments |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
5
|
5
|
1
|
6
|
2
|
7
|
7
|
5
|
13
|
21
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
14
|
15
|
15
|
10
|
4
|
3
|
2
|
0
|
0
|
0
|
|
| Total Assets |
20
N/A
|
20
+3%
|
17
-17%
|
16
-2%
|
7
-59%
|
11
+59%
|
9
-14%
|
5
-41%
|
13
+143%
|
22
+63%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
1
|
4
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Long-Term Debt |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
+9%
|
5
+64%
|
2
-56%
|
3
+13%
|
2
-34%
|
2
-6%
|
2
+6%
|
2
+22%
|
2
-26%
|
|
| Equity | |||||||||||
| Common Stock |
56
|
57
|
57
|
67
|
67
|
77
|
84
|
89
|
104
|
120
|
|
| Retained Earnings |
39
|
40
|
46
|
53
|
63
|
68
|
76
|
85
|
93
|
100
|
|
| Total Equity |
17
N/A
|
17
+1%
|
11
-32%
|
14
+22%
|
4
-70%
|
9
+117%
|
8
-15%
|
4
-50%
|
11
+197%
|
20
+79%
|
|
| Total Liabilities & Equity |
20
N/A
|
20
+3%
|
17
-17%
|
16
-2%
|
7
-59%
|
11
+59%
|
9
-14%
|
5
-41%
|
13
+143%
|
22
+63%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
62
|
66
|
66
|
168
|
168
|
481
|
670
|
850
|
1 051
|
1 189
|
|
Switch to:
Switch to:
See Also
Discover More
